Bausch Health Cos Shares Outstanding 2010-2024 | BHC

Bausch Health Cos shares outstanding from 2010 to 2024. Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. This metric excludes the company's treasury shares.
Bausch Health Cos Annual Shares Outstanding
(Millions of Shares)
2023 365
2022 362
2021 359
2020 355
2019 352
2018 351
2017 352
2016 347
2015 343
2014 342
2013 321
2012 305
2011 326
2010 196
2009 159
Bausch Health Cos Quarterly Shares Outstanding
(Millions of Shares)
2024-09-30 368
2024-06-30 370
2024-03-31 367
2023-12-31 365
2023-09-30 365
2023-06-30 367
2023-03-31 363
2022-12-31 362
2022-09-30 363
2022-06-30 362
2022-03-31 361
2021-12-31 359
2021-09-30 364
2021-06-30 359
2021-03-31 357
2020-12-31 355
2020-09-30 358
2020-06-30 355
2020-03-31 353
2019-12-31 352
2019-09-30 352
2019-06-30 352
2019-03-31 351
2018-12-31 351
2018-09-30 352
2018-06-30 351
2018-03-31 351
2017-12-31 352
2017-09-30 352
2017-06-30 350
2017-03-31 350
2016-12-31 347
2016-09-30 350
2016-06-30 345
2016-03-31 345
2015-12-31 343
2015-09-30 351
2015-06-30 344
2015-03-31 343
2014-12-31 342
2014-09-30 341
2014-06-30 341
2014-03-31 335
2013-12-31 321
2013-09-30 334
2013-06-30 314
2013-03-31 306
2012-12-31 305
2012-09-30 312
2012-06-30 305
2012-03-31 308
2011-12-31 326
2011-09-30 323
2011-06-30 331
2011-03-31 333
2010-12-31 196
2010-09-30 163
2010-06-30 161
2010-03-31 158
2009-12-31 159
2009-09-30 159
2009-06-30 158
2009-03-31 158
Sector Industry Market Cap Revenue
Medical Medical - Generic Drugs $3.012B $8.757B
Bausch Health Companies Inc. develops, manufactures and markets a wide array of branded, generic and branded generic pharmaceuticals, over-the-counter (OTC) products along with medical devices such as contact lenses, intraocular lenses, ophthalmic surgical equipment, and aesthetics devices in the therapeutic areas of eye-health, gastroenterology (GI), and dermatology.
Stock Name Country Market Cap PE Ratio
Teva Pharmaceutical Industries (TEVA) Israel $19.044B 6.25
Dr Reddy's Laboratories (RDY) India $11.978B 22.92
BridgeBio Pharma (BBIO) United States $4.260B 0.00
Amphastar Pharmaceuticals (AMPH) United States $2.097B 12.61
Supernus Pharmaceuticals (SUPN) United States $1.962B 26.71
Taysha Gene Therapies (TSHA) United States $0.434B 30.29
Personalis (PSNL) United States $0.261B 0.00
Assembly Biosciences (ASMB) United States $0.098B 0.00
Sol-Gel Technologies (SLGL) Israel $0.012B 0.00
Evoke Pharma (EVOK) United States $0.007B 0.00
Teligent (TLGT) United States $0.000B 0.00